Chronic Disease Management

On this page

Chronic Disease Overview - The Long Haul

  • Definition: Conditions of long duration & slow progression, requiring ongoing medical attention or limiting activities of daily living.
  • Burden (India): Non-Communicable Diseases (NCDs) cause ~63% of all deaths. Major NCDs: cardiovascular diseases, diabetes, chronic respiratory diseases, cancers.
  • Goals of Chronic Disease Management (CDM):
    • Improve patient Quality of Life (QoL) & functional status.
    • Prevent/delay complications & disease progression.
    • Promote patient self-management, education & adherence.
    • Optimize resource utilization for cost-effective care.
    • Integrated, patient-centered, team-based approach. Chronic Disease Patient Stratification Pyramid

⭐ India aims to reduce premature mortality from NCDs by 25% by 2025 (aligns with WHO "25x25" global target).

Key Players: DM & HTN - Sugar & Pressure Saga

  • Diabetes Mellitus (DM):
    • Screen: Indian adults >30y, or BMI >23kg/m² + risk factors.
    • Dx: FPG ≥126, 2h-PG(75g OGTT) ≥200, HbA1c ≥6.5%, RPG ≥200+symptoms. (mg/dL for PG values)
    • Targets: HbA1c <7% (indiv.); FPG 80-130mg/dL.
  • Hypertension (HTN):
    • Screen: All adults ≥18 yrs.
    • Dx: Clinic BP ≥140/90 mmHg (avg ≥2 readings, ≥2 occ.). Confirm HBPM/ABPM.
    • Targets: General <140/90; High-risk (DM, CKD) <130/80 mmHg.
  • 📌 ABCDE of DM care: A1c, Blood pressure, Cholesterol, Diet/Drugs, Exercise/Eye exam.
  • Target Organ Damage (TOD): Retinopathy, Nephropathy, Neuropathy, CAD, Stroke.

Type 2 Diabetes Mellitus Management Algorithm

⭐ In HTN with compelling indications like DM, ACE inhibitors or ARBs are preferred first-line agents due to renal protective effects.

Lifestyle & Adherence - Daily Dose of Wellness

  • Diet:
    • DASH: Fruits, vegetables, low-fat dairy; ↓Na (<2.3g/day, ideal <1.5g/day), ↓sat fat.
    • Mediterranean: Healthy fats, nuts, fish.
  • Exercise:
    • Aerobic: ≥150 min/mod or ≥75 min/vigorous weekly.
    • Strength: ≥2 days/week.
  • Weight: Target BMI 18.5-24.9 kg/m².
  • Smoking Cessation: 5 A's (Ask, Advise, Assess, Assist, Arrange). NRT, Varenicline. DASH Eating Plan: Eat This vs. Limit This
  • Alcohol: Limit: ≤1 drink/day (women), ≤2 (men).
  • Adherence:
    • Simplify regimen (📌 KISS).
    • Educate, motivate. Regular follow-up.

    ⭐ Non-adherence to treatment plans for chronic diseases can be as high as 50-60%.

Monitoring & Complications - Eye on the Prize

  • Goal: Early detection & management of complications.
  • Diabetes Mellitus (DM):
    • Targets: HbA1c <7%, BP <130/80 mmHg, LDL <100 mg/dL (or <70 mg/dL if CVD).
    • Microvascular: Retinopathy (annual fundoscopy), Nephropathy (annual UACR >30 mg/g), Neuropathy (annual foot exam).
    • Macrovascular: Coronary Artery Disease (CAD), Stroke, Peripheral Artery Disease (PAD).
  • Hypertension (HTN):
    • Targets: BP <140/90 mmHg; <130/80 mmHg (DM, CKD, high ASCVD risk).
    • End-Organ Damage: Left Ventricular Hypertrophy (LVH) (ECG), Chronic Kidney Disease (CKD) (KFT, urine), Retinopathy, Stroke.
  • Red Flags (Referral):
    • Vision loss, chest pain, foot ulcers, neurological deficits, worsening renal function. Diabetic Complications: Microvascular & Macrovascular

⭐ Microalbuminuria (UACR 30-300 mg/g) is the earliest detectable stage of diabetic nephropathy.

High‑Yield Points - ⚡ Biggest Takeaways

  • Diabetes: Target HbA1c <7%; metformin first-line; manage DKA/HHS.
  • Hypertension: Target BP <130/80 mmHg; lifestyle modification is key.
  • COPD/Asthma: Spirometry for diagnosis; stepwise management; avoid triggers.
  • CKD: GFR staging; control BP & glucose; manage anemia.
  • CAD: Risk factor control; statins & antiplatelets are vital.
  • Heart Failure: NYHA classification; ACEi/ARBs, beta-blockers crucial.
  • Multimorbidity: Patient-centered approach; review polypharmacy regularly.

Practice Questions: Chronic Disease Management

Test your understanding with these related questions

Which of the following is not a measure of primary prevention of hypertension?

1 of 5

Flashcards: Chronic Disease Management

1/5

Pellagra (from severe B3 deficiency) may be caused by _____ disease, malignant carcinoid syndrome, and isoniazid therapy

TAP TO REVEAL ANSWER

Pellagra (from severe B3 deficiency) may be caused by _____ disease, malignant carcinoid syndrome, and isoniazid therapy

Hartnup

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial